Search hospitals > Texas > Dallas
UT Southwestern/Simmons Cancer Center-Dallas
Claim this profileDallas, Texas 75390
Global Leader in Cancer
Global Leader in Leukemia
Conducts research for Recurrence
Conducts research for Tumors
Conducts research for Lymphoma
688 reported clinical trials
68 medical researchers
Summary
UT Southwestern/Simmons Cancer Center-Dallas is a medical facility located in Dallas, Texas. This center is recognized for care of Cancer, Leukemia, Recurrence, Tumors, Lymphoma and other specialties. UT Southwestern/Simmons Cancer Center-Dallas is involved with conducting 688 clinical trials across 650 conditions. There are 68 research doctors associated with this hospital, such as Martha M. Pacheco, David Miller, MD, Patrick Leavey, MD, and Syed M. Kazmi.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Leukemia
Global LeaderStage II
Stage I
CD5 positive
Top PIs
Martha M. PachecoSaint Luke's Cancer Institute - Boise7 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
36 reported clinical trials
87 drugs studied
David Miller, MDParkland Memorial Hospital2 years of reported clinical research
Expert in Cancer
Studies Ovarian Cancer
20 reported clinical trials
39 drugs studied
Patrick Leavey, MDUT Southwestern/Simmons Cancer Center-Dallas3 years of reported clinical research
Studies Tumors
Studies Sarcoma
16 reported clinical trials
34 drugs studied
Syed M. KazmiUT Southwestern/Simmons Cancer Center-Dallas1 year of reported clinical research
Expert in Colorectal Cancer
Studies Colon Cancer
17 reported clinical trials
33 drugs studied
Clinical Trials running at UT Southwestern/Simmons Cancer Center-Dallas
Cancer
Prostate Cancer
Lung Cancer
Breast Cancer
Colorectal Cancer
Renal Cell Carcinoma
Acute Myeloid Leukemia
Non-Small Cell Lung Cancer
Acute Leukemia
Lymphoma
Reduced-Intensity Chemoradiation
for Anal Cancer
This phase II trial studies how well lower-dose chemotherapy plus radiation (chemoradiation) therapy works in comparison to standard-dose chemoradiation in treating patients with early-stage anal cancer. Drugs used in chemotherapy, such as mitomycin, fluorouracil, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high-energy x-rays to kill tumor cells and shrink tumors. Giving chemotherapy with radiation therapy may kill more tumor cells. This study may help doctors find out if lower-dose chemoradiation is as effective and has fewer side effects than standard-dose chemoradiation, which is the usual approach for treatment of this cancer type.
Recruiting3 awards Phase 25 criteria
SRT vs GammaTile Therapy
for Brain Tumor
This trial will be a randomized controlled study comparing the efficacy and safety of intraoperative radiation therapy using GammaTilesTM (GT) versus SRT 3-4 weeks following metastatic tumor resection which is the current standard of care.
Recruiting2 awards Phase 3
Focused Radiation vs Systemic Therapy
for Kidney Cancer
This phase III trial compares the effect of stero-ablative radiotherapy (SAbR) followed by standard of care systemic therapy, to standard of care systemic therapy alone, in patients with kidney cancer that has spread from where it first started (primary site) to a limited (2-5) number of places in the body (metastatic). Study doctors want to find out if this approach is better or worse than the usual approach for metastatic kidney cancer. The usual approach is defined as the care most people get for metastatic kidney cancer which includes systemic therapy such as immunotherapy (given through the veins) and/or small molecular inhibitor (tablets taken by mouth). Radiotherapy uses high energy x-rays to kill cancer cells and shrink tumors. SAbR uses special equipment to position a patient and deliver radiation to tumors with high precision. Giving SAbR prior to systemic therapy may kill more tumor cells than the usual approach, which is systemic therapy alone.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at UT Southwestern/Simmons Cancer Center-Dallas?
UT Southwestern/Simmons Cancer Center-Dallas is a medical facility located in Dallas, Texas. This center is recognized for care of Cancer, Leukemia, Recurrence, Tumors, Lymphoma and other specialties. UT Southwestern/Simmons Cancer Center-Dallas is involved with conducting 688 clinical trials across 650 conditions. There are 68 research doctors associated with this hospital, such as Martha M. Pacheco, David Miller, MD, Patrick Leavey, MD, and Syed M. Kazmi.
Where is UT Southwestern/Simmons Cancer Center-Dallas located?
The UT Southwestern/Simmons Cancer Center-Dallas is located at 2201 Inwood Rd, Dallas, TX 75390, USA. For detailed directions, please call 214-648-6264.
Who should I call to ask about financial aid or insurance network?
**UT Southwestern/Simmons Cancer Center-Dallas Financial and Insurance Information**
- **Billing and Insurance**: For inquiries, call 469-291-2000 or 866-648-2455. Secure messaging is available via MyChart under the Billing and Inquiries tab, selecting Billing Account Summary. In-person assistance is provided at Clements University Hospital, 6201 Harry Hines Blvd., Dallas, TX 75235, from 7:30 a.m. to 4:00 p.m.
- **Financial Assistance**: Application forms are available in English and Spanish on the UT Southwestern Medical Center website or in person at the William P. Clements Jr. University Hospital Admission Office. For assistance, call 469-291-2000 or 866-648-2455. Submit applications to FinancialAssistance@ UT Southwestern Medical Center, P.O. Box 36423, Dallas, Texas 75235-9662.
- **Financial Aid (Education)**: Contact the Office of Student Financial Aid at 214-648-3611 or via email at financialaid@utsouthwestern.edu. The office is located at M2.200 on South Campus, adjacent to Bryan Williams, M.D. Student Center.
What insurance does UT Southwestern/Simmons Cancer Center-Dallas accept?
UT Southwestern Medical Center, including Simmons Cancer Center-Dallas, accepts most major insurance plans. Not all UT Southwestern faculty providers participate in all plans, so it's recommended to contact the specific clinical practice or hospital to verify acceptance of your plan. For specific information on insurance plans accepted by Simmons Cancer Center-Dallas, contact them directly or visit their website.
What awards or recognition has UT Southwestern/Simmons Cancer Center-Dallas received?
UT Southwestern/Simmons Cancer Center-Dallas, located in Dallas, Texas, is a leading institution in cancer research and care, supported by grants from prestigious organizations including the National Cancer Institute (NCI), Alex’s Lemonade Stand Foundation (ALSF), American Cancer Society (ACS), and the Cancer Prevention Research Institute of Texas (CPRIT). These funds facilitate critical initiatives in breast cancer research, lung cancer screening, tobacco cessation programs, and the advancement of diagnostic and treatment methods through artificial intelligence and digital pathology. Notably, the center has been awarded nearly $19 million in CPRIT funding in 2024 and nearly $15 million in 2023 for its groundbreaking cancer research projects.